undefined
EUTM file information

018209731

TRIVAIR


March 10, 2020

Trademark Summary

The trademark application TRIVAIR was filed by Acerus Biopharma Inc., a corporation established under the laws of Canada (the "Applicant"). The application was published for oppositions on July 13, 2020, and it was registered by office on October 20, 2020 without any oppositions.

The application was filed in English (French was selected as the second language).

Change of name and address of the trademark registration was recorded on June 23, 2022.


Goods And Services

  • The mark was filed in class 5 with following description of goods:
    1. Inhalers filled with pharmaceutical preparations for use in the treatment of respiratory diseases, disorders and infections
    2. Inhalers filled with pharmaceutical preparations for use in the treatment of asthma
    3. Inhalers filled with pharmaceutical preparations for use in the treatment of chronic obstructive pulmonary disease
    4. Inhalers filled with pharmaceutical preparations for use in the treatment of rhinitis
    5. Inhalers filled with pharmaceutical preparations for use in the treatment of sinus polyps
    6. Inhalers filled with pharmaceutical preparations for use in the treatment of viral airway infections
    7. Inhalers filled with pharmaceutical preparations for use in the treatment of multiple sclerosis
    8. Inhalers filled with pharmaceutical preparations for use in the treatment of depression
    9. Inhalers filled with pharmaceutical preparations for use in the treatment of epilepsy
    10. Inhalers filled with pharmaceutical preparations for use in the treatment of migraine
    11. Inhalers filled with pharmaceutical preparations for use in the treatment of Alzheimer's disease
    12. Inhalers filled with pharmaceutical preparations for use in the treatment of Parkinson's disease
    13. Inhalers filled with pharmaceutical preparations for use in the treatment of cerebrovascular accident or stroke
    14. Inhalers filled with pharmaceutical preparations for use in the treatment of traumatic brain injury
    15. Inhalers filled with pharmaceutical preparations for use in the treatment of cancer
    16. Inhalers filled with pharmaceutical preparations for use in the treatment of nausea
    17. Inhalers filled with pharmaceutical preparations for use in the treatment of post-traumatic stress disorder
    18. Inhalers filled with pharmaceutical preparations for use in the treatment of amyotrophic lateral sclerosis
    19. Inhalers filled with pharmaceutical preparations for use in the treatment of chronic pain
    20. Inhalers filled with pharmaceutical preparations for use in the treatment of insomnia
    21. Inhalers filled with pharmaceutical preparations for use in the relief of pain
    22. Inhalers filled with pharmaceutical preparations for use in the treatment of cough or sore throat
    23. Inhalers filled with pharmaceutical preparations for use in the treatment of candida infection
    24. Inhalers filled with pharmaceutical preparations for use in anti-fungal treatment
    25. Inhalers filled with pharmaceutical preparations for use in sedation
    26. Inhalers filled with pharmaceutical preparations for use in hormone replacement therapy
    27. Inhalers filled with pharmaceutical preparations for use in the treatment of psychosis
    28. Drug delivery devices, namely, breath actuated nasal delivery devices filled with pharmaceutical preparations for use in the treatment of respiratory diseases, disorders and infections
    29. Drug delivery devices, namely, breath actuated nasal delivery devices filled with pharmaceutical preparations for use in the treatment of asthma
    30. Drug delivery devices, namely, breath actuated nasal delivery devices filled with pharmaceutical preparations for use in the treatment of chronic obstructive pulmonary disease
    31. Drug delivery devices, namely, breath actuated nasal delivery devices filled with pharmaceutical preparations for use in the treatment of rhinitis
    32. Drug delivery devices, namely, breath actuated nasal delivery devices filled with pharmaceutical preparations for use in the treatment of sinus polyps
    33. Drug delivery devices, namely, breath actuated nasal delivery devices filled with pharmaceutical preparations for use in the treatment of viral airway infections
    34. Drug delivery devices, namely, breath actuated nasal delivery devices filled with pharmaceutical preparations for use in the treatment of multiple sclerosis
    35. Drug delivery devices, namely, breath actuated nasal delivery devices filled with pharmaceutical preparations for use in the treatment of depression
    36. Drug delivery devices, namely, breath actuated nasal delivery devices filled with pharmaceutical preparations for use in the treatment of epilepsy
    37. Drug delivery devices, namely, breath actuated nasal delivery devices filled with pharmaceutical preparations for use in the treatment of migraine
    38. Drug delivery devices, namely, breath actuated nasal delivery devices filled with pharmaceutical preparations for use in the treatment of Alzheimer's disease
    39. Drug delivery devices, namely, breath actuated nasal delivery devices filled with pharmaceutical preparations for use in the treatment of Parkinson's disease
    40. Drug delivery devices, namely, breath actuated nasal delivery devices filled with pharmaceutical preparations for use in the treatment of cerebrovascular accident or stroke
    41. Drug delivery devices, namely, breath actuated nasal delivery devices filled with pharmaceutical preparations for use in the treatment of traumatic brain injury
    42. Drug delivery devices, namely, breath actuated nasal delivery devices filled with pharmaceutical preparations for use in the treatment of cancer
    43. Drug delivery devices, namely, breath actuated nasal delivery devices filled with pharmaceutical preparations for use in the treatment of nausea
    44. Drug delivery devices, namely, breath actuated nasal delivery devices filled with pharmaceutical preparations for use in the treatment of post-traumatic stress disorder
    45. Drug delivery devices, namely, breath actuated nasal delivery devices filled with pharmaceutical preparations for use in the treatment of amyotrophic lateral sclerosis
    46. Drug delivery devices, namely, breath actuated nasal delivery devices filled with pharmaceutical preparations for use in the treatment of chronic pain
    47. Drug delivery devices, namely, breath actuated nasal delivery devices filled with pharmaceutical preparations for use in the treatment of insomnia
    48. Drug delivery devices, namely, breath actuated nasal delivery devices filled with pharmaceutical preparations for use in the relief of pain
    49. Drug delivery devices, namely, breath actuated nasal delivery devices filled with pharmaceutical preparations for use in the treatment of cough or sore throat
    50. Drug delivery devices, namely, breath actuated nasal delivery devices filled with pharmaceutical preparations for use in the treatment of candida infection
    51. Drug delivery devices, namely, breath actuated nasal delivery devices filled with pharmaceutical preparations for use in anti-fungal treatment
    52. Drug delivery devices, namely, breath actuated nasal delivery devices filled with pharmaceutical preparations for use in sedation
    53. Drug delivery devices, namely, breath actuated nasal delivery devices filled with pharmaceutical preparations for use in hormone replacement therapy
    54. Drug delivery devices, namely, breath actuated nasal delivery devices filled with pharmaceutical preparations for use in the treatment of psychosis
    55. Inhalers used to deliver therapeutic agents, namely analgesics, sedatives, vaccines, anesthetics, insulin, cannabis, antiemetics, antifungals, hormones, or antipsychotics
    56. Drug delivery devices, namely, breath actuated nasal delivery devices used to deliver therapeutic agents, namely analgesics, sedatives, vaccines, anesthetics, insulin, cannabis, antiemetics, antifungals, hormones, or antipsychotics
    57. Inhalers filled with analgesics, sedatives, vaccines, anesthetics, insulin, cannabis, antiemetics, antifungals, hormones, respiratory therapeutic agents, or antipsychotics
    58. Drug delivery devices, namely, breath actuated nasal delivery devices filled with analgesics, sedatives, vaccines, anesthetics, insulin, cannabis, antiemetics, antifungals, hormones, respiratory therapeutic agents, or antipsychotics.
  • The mark was filed in class 10 with Medical apparatus and instruments, namely inhalers, sold empty, for therapeutic use and medical apparatus and instruments, namely breath actuated nasal drug delivery devices, sold empty, for therapeutic use..